The treatment of scleroderma with the new chelating agent, edathamil.
D001487:Basidiomycota; D002614:Chelating Agents; D004492:Edetic Acid / Q000627:therapeutic use*; D012594:Scleroderma, Localized; D012595:Scleroderma, Systemic / Q000628:therapy*
D002614:Chelating Agents; D004492:Edetic Acid
EDATHAMIL/therapeutic use; SCLERODERMA/therapy